Achalasia: Update on the disease and its treatment

Gastroenterology

Volumn 139, Issue 2, 2010, Pages

  Francis, Dawn L ^a   Katzka, David A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; CALCIUM CHANNEL BLOCKING AGENT; NITRATE; SILDENAFIL; GASTROINTESTINAL AGENT;

DRUG EFFICACY; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGOSCOPY; ESOPHAGUS ACHALASIA; ESOPHAGUS MYOTOMY; ESOPHAGUS RESECTION; GASTROSCOPY; GENETIC PREDISPOSITION; HUMAN; IMMUNOHISTOCHEMISTRY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; ABDOMINAL SURGERY; ESOPHAGUS; PATIENT SELECTION; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

DIGESTIVE SYSTEM SURGICAL PROCEDURES; ESOPHAGEAL ACHALASIA; ESOPHAGOSCOPY; ESOPHAGUS; GASTROINTESTINAL AGENTS; HUMANS; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 77955490552     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.06.024     Document Type: Article

References (68)

1. S. Birgisson, and J.E. Richter Achalasia in Iceland, 1952-2002: an epidemiologic study Dig Dis Sci 52 2007 1855 1860
2. J.F. Mayberry, and M. Atkinson Variations in the prevalence of achalasia in Great Britain and Ireland: an epidemiological study based on hospital admissions Q J Med 62 1987 67 74
3. N. Arber, A. Grossman, B. Lurie, et al. Epidemiology of achalasia in central Israel Rarity of esophageal cancer Dig Dis Sci 38 1993 1920 1925
4. J.F. Mayberry, and M. Atkinson Incidence of achalasia in New Zealand, 1980-1984 An epidemiological study based on hospital discharges J Gastroenterol Hepatol 3 1988 247 257
5. C.M. Stein, M. Gelfand, and H.G. Taylor Achalasia in Zimbabwean blacks S Afr Med J 67 1985 261 262
6. J.F. Mayberry, and M.J. Mayell Epidemiological study of achalasia in children Gut 29 1988 90 93
7. A. Sonnenberg Hospitalization for achalasia in the United States 1997-2006 Dig Dis Sci 54 2009 1680 1685
8. D.T. Stein, and C.M. Knauer Achalasia in monozygotic twins Dig Dis Sci 27 1982 636 640
9. S.B. Clark, T.W. Rice, R.R. Tubbs, et al. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis Am J Surg Pathol 24 2000 1153 1158
10. W. Park, and M.F. Vaezi Etiology and pathogenesis of achalasia: the current understanding Am J Gastroenterol 100 2005 1404 1414
11. R.K. Wong, C.L. Maydonovitch, S.J. Metz, et al. Significant DQw1 association in achalasia Dig Dis Sci 34 1989 349 352
12. A. Ruiz-de-Leon, J. Mendoza, C. Sevilla-Mantilla, et al. Myenteric antiplexus antibodies and class II HLA in achalasia Dig Dis Sci 47 2002 15 19
13. J.L. Santiago, A. Martinez, M.S. Benito, et al. Gender-specific association of the PTPN22 C1858T polymorphism with achalasia Hum Immunol 68 2007 867 870
14. F. Paladini, E. Cocco, I. Cascino, et al. Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene Neurogastroenterol Motil 21 2009 597 602
15. M. Facco, P. Brun, I. Baesso, et al. T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens Am J Gastroenterol 103 2008 1598 1609
16. Kraichely RE, Farrugia G, Pittock SJ, et al. Neural autoantibody profile of primary achalasia. Dig Dis Sci;55:307-311.
17. I. Gockel, J.R. Bohl, V.F. Eckardt, et al. Reduction of interstitial cells of Cajal (ICC) associated with neuronal nitric oxide synthase (n-NOS) in patients with achalasia Am J Gastroenterol 103 2008 856 864
18. J.C. Goin, L. Sterin-Borda, C.R. Bilder, et al. Functional implications of circulating muscarinic cholinergic receptor autoantibodies in chagasic patients with achalasia Gastroenterology 117 1999 798 805
19. N. Stylopoulos, C.J. Bunker, and D.W. Rattner Development of achalasia secondary to laparoscopic Nissen fundoplication J Gastrointest Surg 6 2002 368 6376
20. T. Jomni, X. Dray, M. Merrouche, et al. Achalasia in an obese woman treated by laparoscopic gastric banding Gastroenterol Clin Biol 32 2008 973 975
21. V.F. Eckardt, U. Kohne, T. Junginger, et al. Risk factors for diagnostic delay in achalasia Dig Dis Sci 42 1997 580 585
22. J.E. Richter Oesophageal motility disorders Lancet 358 2001 823 828
23. P. Hart, and D. Francis Barium esophagram remains a highly sensitive screening examination for the diagnosis of achalasia Am J Gastroenterol 104 suppl 3 2009 3
24. P.J. Howard, L. Maher, A. Pryde, et al. Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh Gut 33 1992 1011 1015
25. J.E. Pandolfino, and P.J. Kahrilas AGA technical review on the clinical use of esophageal manometry Gastroenterology 128 2005 209 224
26. P.M. Fisichella, D. Raz, F. Palazzo, et al. Clinical, radiological, and manometric profile in 145 patients with untreated achalasia World J Surg 32 2008 1974 1979
27. A. Agrawal, A. Hila, R. Tutuian, et al. Manometry and impedance characteristics of achalasia Facts and myths J Clin Gastroenterol 42 2008 266 270
28. I. Hirano, R.P. Tatum, G. Shi, et al. Manometric heterogeneity in patients with idiopathic achalasia Gastroenterology 120 2001 789 798
29. M. Gelfond, P. Rozen, and T. Gilat Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation Gastroenterology 83 1982 963 969 (Pubitemid 12028470)
30. G. Coccia, M. Bortolotti, P. Michetti, et al. Return of esophageal peristalsis after nifedipine therapy in patients with idiopathic esophageal achalasia Am J Gastroenterol 87 1992 1705 1708
31. M. Bortolotti, C. Mari, C. Lopilato, et al. Effects of sildenafil on esophageal motility of patients with idiopathic achalasia Gastroenterology 118 2000 253 257
32. P.J. Pasricha, W.J. Ravich, T.R. Hendrix, et al. Treatment of achalasia with intrasphincteric injection of botulinum toxin A pilot trial Ann Intern Med 121 1994 590 591
33. P.J. Pasricha, W.J. Ravich, T.R. Hendrix, et al. Intrasphincteric botulinum toxin for the treatment of achalasia N Engl J Med 332 1995 774 778
34. V. Annese, V. D'Onofrio, and A. Andriulli Botulinum toxin in long-term therapy for achalasia Ann Intern Med 128 1998 696
35. P.J. Pasricha, R. Rai, W.J. Ravich, et al. Botulinum toxin for achalasia: long-term outcome and predictors of response Gastroenterology 110 1996 1410 1415
36. C.D. Smith, A. Stival, D.L. Howell, et al. Endoscopic therapy for achalasia before Heller myotomy results in worse outcomes than Heller myotomy alone Ann Surg 243 2006 579 584
37. S.C. Kadakia, and R.K. Wong Graded pneumatic dilation using Rigiflex achalasia dilators in patients with primary esophageal achalasia Am J Gastroenterol 88 1993 34 38
38. M. Hulselmans, T. Vanuytsel, T. Degreef, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia Clin Gastroenterol Hepatol 8 2010 30 35
39. S.K. Chuah, T.H. Hu, K.L. Wu, et al. Clinical remission in endoscope-guided pneumatic dilation for the treatment of esophageal achalasia: 7-year follow-up results of a prospective investigation J Gastrointest Surg 13 2009 862 867
40. J.C. Reynolds, and H.P. Parkman Achalasia Gastroenterol Clin North Am 18 1989 223 255
41. R.L. West, D.P. Hirsch, J.F. Bartelsman, et al. Long term results of pneumatic dilation in achalasia followed for more than 5 years Am J Gastroenterol 97 2002 1346 1351
42. A. Sanchez-Pernaute, E.P. Aguirre, P. Talavera, et al. Laparoscopic approach to esophageal perforation secondary to pneumatic dilation for achalasia Surg Endosc 23 2009 1106 1109
43. J.E. Leyden, A.C. Moss, and P. MacMathuna Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia Cochrane Database Syst Rev 2006 CD005046
44. G.M. Campos, E. Vittinghoff, C. Rabl, et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis Ann Surg 249 2009 45 57
45. A. Csendes, I. Braghetto, A. Henriquez, et al. Late results of a prospective randomised study comparing forceful dilatation and oesophagomyotomy in patients with achalasia Gut 30 1989 299 304
46. M.F. Vela, J.E. Richter, F. Khandwala, et al. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia Clin Gastroenterol Hepatol 4 2006 580 587
47. G. Zaninotto, C. Rizzetto, P. Zambon, et al. Long-term outcome and risk of oesophageal cancer after surgery for achalasia Br J Surg 95 2008 1488 1494
48. M.J. Rosen, Y.W. Novitsky, W.S. Cobb, et al. Laparoscopic Heller myotomy for achalasia in 101 patients: can successful symptomatic outcomes be predicted? Surg Innov 14 2007 177 183
49. W.S. Melvin, B.J. Needleman, K.R. Krause, et al. Computer-assisted robotic Heller myotomy: initial case report J Laparoendosc Adv Surg Tech A 11 2001 251 253
50. R.A. Malthaner, T.R. Tood, L. Miller, et al. Long-term results in surgically managed esophageal achalasia Ann Thorac Surg 58 1994 1343 1346
51. A. Kilic, M.J. Schuchert, A. Pennathur, et al. Long-term outcomes of laparoscopic Heller myotomy for achalasia Surgery 146 2009 826 831
52. Y.R. Wang, D.T. Dempsey, F.K. Friedenberg, et al. Trends of Heller myotomy hospitalizations for achalasia in the United States, 1993-2005: effect of surgery volume on perioperative outcomes Am J Gastroenterol 103 2008 2454 2464
53. S.M. Eldaif, C.J. Mutrie, W.C. Rutledge, et al. The risk of esophageal resection after esophagomyotomy for achalasia Ann Thorac Surg 87 2009 1558 1562
54. P.D. Scott, K.L. Harold, B.T. Heniford, et al. Results of laparoscopic Heller myotomy for extreme megaesophagus: an alternative to esophagectomy Surg Laparosc Endosc Percutan Tech 19 2009 198 200
55. A. Torquati, R. Lutfi, L. Khaitan, et al. Heller myotomy vs Heller myotomy plus Dor fundoplication: cost-utility analysis of a randomized trial Surg Endosc 20 2006 389 393
56. F. Rebecchi, C. Giaccone, E. Farinella, et al. Randomized controlled trial of laparoscopic Heller myotomy plus Dor fundoplication versus Nissen fundoplication for achalasia: long-term results Ann Surg 248 2008 1023 1030
57. W.O. Richards, A. Torquati, M.D. Holzman, et al. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial Ann Surg 240 2004 405 412
58. J.G. Zhao, Y.D. Li, Y.S. Cheng, et al. Long-term safety and outcome of a temporary self-expanding metallic stent for achalasia: a prospective study with a 13-year single-center experience Eur Radiol 19 2009 1973 1980
59. P.J. Pasricha, R. Hawari, I. Ahmed, et al. Submucosal endoscopic esophageal myotomy: a novel experimental approach for the treatment of achalasia Endoscopy 39 2007 761 764
60. Savides T, Horgan S. Experience with peroral endoscopic myotomy in two patients with achalasia.
61. Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy;42:265-271.
62. D.R. Urbach, P.D. Hansen, Y.S. Khajanchee, et al. A decision analysis of the optimal initial approach to achalasia: laparoscopic Heller myotomy with partial fundoplication, thoracoscopic Heller myotomy, pneumatic dilatation, or botulinum toxin injection J Gastrointest Surg 5 2001 192 205
63. V.F. Eckardt, C. Aignherr, and G. Bernhard Predictors of outcome in patients with achalasia treated by pneumatic dilation Gastroenterology 103 1992 1732 1738
64. L. Melman, J.A. Quinlan, B.L. Hall, et al. Clinical utility of routine barium esophagram after laparoscopic anterior esophageal myotomy for achalasia Surg Endosc 23 2009 606 610
65. A. Oezcelik, J.A. Hagen, J.M. Halls, et al. An improved method of assessing esophageal emptying using the timed barium study following surgical myotomy for achalasia J Gastrointest Surg 13 2009 14 18
66. M.F. Vaezi, M.E. Baker, E. Achkar, et al. Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment Gut 50 2002 765 770
67. V.F. Eckardt, T. Hoischen, and G. Bernhard Life expectancy, complications, and causes of death in patients with achalasia: results of a 33-year follow-up investigation Eur J Gastroenterol Hepatol 20 2008 956 960
68. A. Csendes, I. Braghetto, P. Burdiles, et al. Very late results of esophagomyotomy for patients with achalasia: clinical, endoscopic, histologic, manometric and acid reflux studies in 67 patients for a mean follow-up of 190 months Ann Surg 245 2007 334 335